初级溢出淋巴瘤:针对病毒和细胞机制的治疗策略
Soumaiah Abou Staiteieh1,2, Nouria Faddoul1, Berthe Hayar2
1Genomics and Surveillance Biotherapy Laboratory, Biology Department, Faculty of Sciences, R. Hariri Campus, Lebanese University, Hadath, Lebanon.
针对病毒和细胞通路的新型疗法对原发性输液淋巴瘤 (PEL) 有前途,这是一种罕见的癌症,影响免疫力低下的个体. 目前正在进行研究,以优化这些治疗方法,以获得更好的疗效和降低毒性.
科学领域:
- 在瘤学瘤学.
- 病毒学 病毒学
- 免疫学 免疫学 免疫学
背景情况:
- 初级输液淋巴瘤 (PEL) 是一种罕见的B细胞淋巴瘤,主要影响免疫力低下和老年人.
- 对于PEL的传统治疗方法已经显示出有限的疗效,生存率令人丧.
- 了解PEL病原体对于开发改进的治疗策略至关重要.
研究的目的:
- 审查针对病毒和细胞机制的PEL新疗法选择.
- 探索传统化疗和干细胞移植之外的替代治疗方法.
- 确定有前途的药物和途径,以提高PEL治疗的疗效和尽量减少毒性.
主要方法:
- 在PubMed和谷歌学者数据库中进行全面的文献搜索.
- 包括1989年至2024年间发表的研究.
- 专注于治疗目标,包括病毒途径,DNA损伤,表观遗传学,亡和免疫调节.
主要成果:
- 针对特定病毒和细胞通路的新型治疗剂显示出有希望的临床前和临床结果.
- 抗逆转录病毒药物和调节细胞过程的治疗方法显示了提高PEL治疗疗效的潜力.
- 与传统疗法相比,研究中的治疗方法旨在最大限度地降低毒性.
结论:
- 向治疗为改善原发性输液淋巴瘤的结果提供了一个有希望的途径.
- 需要进一步的研究来完善组合策略和药物相互作用,以获得最佳的治疗疗效.
- 进一步研究向疗法可以提高治疗的有效性,并减少PEL患者的不良影响.
更多相关视频
08:49Transduction and Expansion of Primary T Cells in Nine Days with Maintenance of Central Memory Phenotype
Published on: March 18, 2020
08:52Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant
Published on: May 27, 2011
相关概念视频
Targeted Cancer Therapies
There are several types of targeted therapies against...
Tumor Immunotherapy
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
